Back to Market返回行情

DH Definitive Healthcare Corp.

USHealthcare
$0.8017-1.26%ClosedMarket Cap: $84.6M

As of 2026-07-09 16:00

Why DH matters now

Definitive Healthcare Corp. (DH) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.80 with -1.26% on the session and $84.6M in market capitalization; recent performance reads 1-month -12.75% and YTD -73.52%.

The latest financial table shown here is Q1 2026, with revenue of $55.9M, net income of $-138.6M, and EPS of $-1.32. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 46.2%.

The latest indexable market news headline is "Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success" from PRNewsWire.

Additional event context on this page matters because analyst consensus is Hold with a median target of $1.10; recent insider activity includes Hamood Samuel A filing A-Award. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

0.54

P/S

0.34

EV/EBITDA

7.96

DCF Value

$-9.59

FCF Yield

46.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

72.5%

Operating Margin

66.9%

Net Margin

-71.5%

ROE

-67.1%

ROA

-33.1%

ROIC

40.9%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$55.9M$-138.6M$-1.32
Q4 2025$61.5M$-9.3M$-0.09
FY 2025$241.5M$-138.9M$-1.30
Q3 2025$60.0M$-14.8M$-0.14

Analyst Ratings

Consensus

Hold

Target (Consensus)

$1.10

Target (Median)

$1.10

Target Range

$1.10 - $1.10

Strong Buy: 0Buy: 3Hold: 6Sell: 0Strong Sell: 1
BarclaysUnderweight
2026-03-30
Stephens & Co.Equal Weight
2026-02-27
Canaccord GenuityHold
2026-02-27
BarclaysUnderweight
2025-12-09
Canaccord GenuityHold
2025-11-10

Trading Activity

Insider Trades

Hamood Samuel Adirector
Sell2026-06-09
Chilukuri Sastrydirector
Sell2026-06-08
Winters Kathleen Adirector
Sell2026-06-08
Stephenson Scott Gdirector
Sell2026-06-08
Heller Caseyofficer: Chief Financial Officer
Sell2026-05-05

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

US

Exchange

Beta

1.33

Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.